Latest news
Arrowhead buys PRV for $215M; Twist hopes to raise $300M in public offering - Endpoints NewsEndpoints News · Wed, 05 Aug 2026 14:28:00 GMTIonis’ top scientist Frank Bennett to retire; Recursion selects its first AI chief - Endpoints NewsEndpoints News · Fri, 31 Jul 2026 07:00:00 GMTAlnylam cuts Amvuttra sales guidance as demand shifts, hurting stock - Endpoints NewsEndpoints News · Thu, 30 Jul 2026 07:00:00 GMTAlnylam’s stock is down 30% despite a booming biotech market. Here’s why - Endpoints NewsEndpoints News · Tue, 28 Jul 2026 07:00:00 GMT